Imperva Announces Record Second Quarter 2015 Financial Results

Go back to Imperva Announces Record Second Quarter 2015 Financial Results

Imperva (IMPV) PT Raised to $88 at Needham & Company Amid Strong June Quarter

August 7, 2015 7:47 AM EDT

Needham & Company analyst Scott Zeller reiterated a Buy rating and boosted his price target on Imperva (NYSE: IMPV) to $88.00 (from $67.00) after a strong June quarter.

Zeller commented, "The IMPV JuneQ results were very strong, and license accelerated (a bit)... More

Oppenheimer Raises Price Target on Imperva (IMPV) to $80 Following 2Q15 Results

August 7, 2015 7:03 AM EDT

Oppenheimer reiterated an Outperform rating on Imperva (NYSE: IMPV), and raises the price target to $80.00 (from $75.00), following 2Q15 results. Revenue of $53.5M (up 39% YoY) bested consensus $48.7M estimate. Loss per share of $0.08 came in better than our and Street's estimate of $0.21. For... More

Imperva (IMPV) Tops Q2 EPS by 13c, Q3 & FY Guidance Beats

August 6, 2015 4:30 PM EDT

Imperva (NYSE: IMPV) reported Q2 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $53.5 million versus the consensus estimate of $48.55 million.

Imperva sees Q3 2015 EPS of $0.05-$0.06, versus the consensus of ($0.16). Imperva sees Q3 2015 revenue of $55-57... More